AYActive Study! A Physical Health Activity Intervention

May 11, 2023 updated by: Lucas Carr
The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics.

Study Overview

Status

Completed

Conditions

Detailed Description

The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics. Eligible participants will receive a Fitbit activity monitor and access to the mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races. AYA cancer survivors between 13-39 years are invited to participate and the impact of this intervention will be tested over 6 weeks.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 39 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male and female cancer survivors
  • Diagnosed between 13 and 39 years old
  • Currently 3-24 months post-treatment (or in maintenance therapy)
  • Receiving survivorship care at HCCC/UIHC
  • In remission
  • Physically able to walk without limitations
  • Own a smartphone with a data plan that is also capable of receiving and sending texts
  • Able to understand English and provide informed assent/consent

Exclusion Criteria:

  • Physically unable to walk without limitations
  • Actively receiving cancer treatment
  • Does not own a smartphone with a data plan
  • Visual or cognitive impairments causing inability to read, complete or sign the consent form and survey
  • Participants with diagnosis of thyroid cancer (due to differences in physical, psychological, emotional, and social effects)
  • Presence of a psychiatric disorder that is not managed/unstable or suicidal ideation/actuation in preceding 12 months
  • Currently meeting physical activity requirements per American Cancer Society guidelines (150 or more minutes per week of moderate to vigorous physical activity)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants will receive a Fitbit activity monitor and access to the mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
Eligible participants will receive a Fitbit activity monitor and access to our mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of steps taken per day
Time Frame: Dail steps will be measured each day of the intervention for 7 weeks
Number of steps taken per day on each day of the intervention
Dail steps will be measured each day of the intervention for 7 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS Fatigue Scale
Time Frame: Change in fatigue over 7 weeks
8 item scale, lower score is better
Change in fatigue over 7 weeks
PROMISE Pain Scale
Time Frame: Change in pain over 7 weeks
8 item scale, lower score is better
Change in pain over 7 weeks
PROMIS Physical Function Scale
Time Frame: Change in physical function over 7 weeks
8 item scale, lower score is better
Change in physical function over 7 weeks
PROMIS Depression Scale
Time Frame: Change in depression over 7 weeks
8 item scale, lower score is better
Change in depression over 7 weeks
PROMIS Anxiety Scale
Time Frame: Change in anxiety over 7 weeks
8 item scale, lower score is better
Change in anxiety over 7 weeks
Exercise Self-Regulatory Efficacy
Time Frame: Change in exercise self regulatory efficacy over 7 weeks
20 item scale, higher score is better
Change in exercise self regulatory efficacy over 7 weeks
Social Support for exercise
Time Frame: Change in social support for exercise over 7 weeks
13 item scale, higher score is better
Change in social support for exercise over 7 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Lucas Carr, PhD, University of Iowa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 6, 2019

Primary Completion (Actual)

September 4, 2020

Study Completion (Actual)

September 4, 2020

Study Registration Dates

First Submitted

November 18, 2019

First Submitted That Met QC Criteria

October 20, 2020

First Posted (Actual)

October 26, 2020

Study Record Updates

Last Update Posted (Actual)

May 16, 2023

Last Update Submitted That Met QC Criteria

May 11, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 201907702

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on mHealth Activity Intervention

3
Subscribe